The Current Ratio as of December 2025 (TTM) for BriaCell Therapeutics Corp. (BCTX) is 3.41

According to BriaCell Therapeutics Corp.’s latest financial reports and current stock price. The company's current Current Ratio is 3.41. This represents a change of 97.33% compared to the average of 1.73 of the last 4 quarters.

BriaCell Therapeutics Corp. (BCTX) Historical Current Ratio (quarterly & annually)

How has BCTX Current Ratio performed in the past?

The mean historical Current Ratio of BriaCell Therapeutics Corp. over the last ten years is 19.55. The current 3.41 Current Ratio has changed 1.65% with respect to the historical average. Over the past ten years (40 quarters), BCTX's Current Ratio was at its highest in in the January 2017 quarter at 181.79. The Current Ratio was at its lowest in in the January 2021 quarter at 0.05.

BriaCell Therapeutics Corp. (BCTX) Current Ratio by Quarter and Year

Discovering the peaks and valleys of BriaCell Therapeutics Corp. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

BriaCell Therapeutics Corp. (BCTX) Average Current Ratio

How has BCTX Current Ratio performed in the past?

The current Current Ratio of BriaCell Therapeutics Corp. (BCTX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

BriaCell Therapeutics Corp. (BCTX) Current Ratio vs. Peers

How is BCTX’s Current Ratio compared to its peers?

BriaCell Therapeutics Corp.’s Current Ratio is less than Processa Pharmaceuticals, Inc. (3.45), greater than Curis, Inc. (0.70), greater than Entero Therapeutics, Inc. (2.62), greater than Leap Therapeutics, Inc. (1.34), greater than Palisade Bio, Inc. (1.96), less than Hoth Therapeutics, Inc. (27.57), greater than Allarity Therapeutics, Inc. (2.33), greater than Moleculin Biotech, Inc. (1.39), greater than Aspire Biopharma Holdings, Inc. (0.17), greater than Citius Pharmaceuticals, Inc. (0.47),

Build a custom stock screener for BriaCell Therapeutics Corp. (BCTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BriaCell Therapeutics Corp. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

BriaCell Therapeutics Corp. (BCTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like BriaCell Therapeutics Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.